Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease

Condition:   Primary Disease Intervention:   Drug: VPRIV Sponsor:   Shaare Zedek Medical Center Recruiting

Source: ClinicalTrials.gov - October 11, 2018 Category: Research Source Type: clinical trials